Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This heart disease dataset is curated by combining 3 popular heart disease datasets. The first dataset (Collected from Kaggle) contains 70000 records with 11 independent features which makes it the largest heart disease dataset available so far for research purposes. These data were collected at the moment of medical examination and information given by the patient. Second and third datasets contain 303 and 293 intstances respectively with 13 common features. The three datasets used for its curation are:Cardio Data (Kaggle Dataset)Cleveland (UCI Machine Learning Repository)Hungarian (UCI Machine Learning Repository)
Eye Disease Dataset
Description
The Eye Disease Dataset is a collection of images related to various eye diseases. It provides a valuable resource for training and evaluating computer vision models for eye disease detection and classification. The dataset includes images representing five different eye disease classes: Bulging Eyes, Cataracts, Crossed Eyes, Glaucoma, and Uveitis.
Dataset Details
Dataset Name: Falah/eye-disease-dataset
Number of… See the full description on the dataset page: https://huggingface.co/datasets/Falah/eye-disease-dataset.
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
The dataset is the Cleveland Heart Disease dataset taken from the UCI repository. The dataset consists of 303 individuals’ data. There are 14 columns in the dataset(which have been extracted from a larger set of 75). No missing values. The classification task is to predict whether an individual is suffering from heart disease or not. (0: absence, 1: presence)
original data: https://archive.ics.uci.edu/ml/datasets/Heart+Disease
This database contains 13 attributes and a target variable. It has 8 nominal values and 5 numeric values. The detailed description of all these features are as follows:
Absence (1) or presence (2) of heart disease
Cost Matrix
abse pres
absence 0 1 presence 50
where the rows represent the true values and the columns the predicted.
No missing values.
303 observations
Creators: 1. Hungarian Institute of Cardiology. Budapest: Andras Janosi, M.D. 2. University Hospital, Zurich, Switzerland: William Steinbrunn, M.D. 3. University Hospital, Basel, Switzerland: Matthias Pfisterer, M.D. 4. V.A. Medical Center, Long Beach and Cleveland Clinic Foundation: Robert Detrano, M.D., Ph.D.
Donor: David W. Aha (aha '@' ics.uci.edu) (714) 856-8779
Predicting Coronary Heart Disease by Non-Invasive Means
Open Database License (ODbL) v1.0https://www.opendatacommons.org/licenses/odbl/1.0/
License information was derived automatically
Le système d’assurance maladie créé en 1945 permet à la France d’afficher de bons résultats en termes d’espérance de vie. Pour autant, la prévalence de pratiques à risque, un taux de mortalité infantile élevé et des inégalités croissantes d’accès aux soins nuancent ces résultats, obtenus en outre au prix de déficits récurrents. La France se caractérise aussi par une dépense de santé élevée en proportion du PIB et par la part importante des assurances complémentaires dans son financement. Face à l’augmentation structurelle des dépenses, alors que les outils actuels de régulation ont atteint leurs limites, la qualité et l’égalité d’accès aux soins ne pourront être maintenues ou renforcées qu’en réformant l’organisation et la gestion du système de santé. Ce rapport est accessible sur le site de la Cour. Les fichiers publiés correspondent aux données ayant servi de base à l'élaboration du rapport.
Open Data Commons Attribution License (ODC-By) v1.0https://www.opendatacommons.org/licenses/by/1.0/
License information was derived automatically
During the COVID-19 pandemic, the national monitoring project "COVID-19 Barometer" was started by the "Consortium Eerstelijnsdata". The aim of this barometer is follow-up of the extra muros (general practitioners, coordinating and advisory physicians, triage posts, pharmacists, midwives, home nurses, ...) with regard to the execution of the critical tasks, the quality of execution of tasks, the need for help, the available capacity, the number infections, and the availability of medical equipment.
This data also aims to support the COVID19 Risk Assessment Group, COVID19 Risk Management Group, and the National Crisis Cell.
This registration was notified to, and assessed and authorized by, the Chamber Social Security and Health of the Information Security Committee (Reference IVC / KSZG / 20/134).
Daily situation updates and data regarding the COVID-19 outbreak
The dataset contains tweets in French mentioning natural hazards (pests and diseases), between 2008 and 2021.
pest_tweets_without_userid.csv, disease_tweets_without_userid.csv, JNO_tweets.csv and pyrale_tweets.csv, corvidae_tweets.csv tweet_RT are collections of tweets, each of these .csv files contains all or several of the following columns:
tweet_users.csv is a list of the users of the collected tweets. It contains the following columns:
tweet_places.csv is a table of all mentioned places in the tweet collections. It contains the following columns:
https://www.databridgemarketresearch.com/privacy-policyhttps://www.databridgemarketresearch.com/privacy-policy
Report Metric |
Details |
Forecast Period |
2024 to 2031 |
Base Year |
2023 |
Historic Years |
2022 (Customizable to 2016-2021) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Product and Service (Product Type and Services), Test (Routine Laboratory Tests, Inflammatory Markets, Autoantibodies and Immunologic Tests Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis, and Others Tests and Others), Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Scleroderma, Systemic Autoimmune Disease and Localized Autoimmune Disease), End User (Hospitals, Clinical Labs) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
Market Players Covered |
Siemens AG (Germany), Abbott (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher (U.S.), Grifols, S.A. (Spain), Bio-Rad Laboratories Inc. (U.S.), ProtaGene (Germany), HYCOR Biomedical (U.S.), Nova (U.S.), Trinity Biotech (Ireland), EUROIMMUN Medizinische Labordiagnostika AG (Germany), Quest (U.S.), Hemagen Diagnostics Inc. (U.S.), Crescendo Biologics Ltd (U.S.), AESKU GROUP GmbH (Germany), SQI Diagnostics (Canada), Seramun Diagnostica GmbH (Germany) |
Market Opportunities |
|
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Data are downloaded from PADI-web for the period from 1st January to 28th June 2016 for the four studied diseases, i‧e. African swine fever (ASF), foot-and-mouth disease (FMD), bluetongue (BTV), and avian influenza (AI). This dataset indicates information associated with "extraction information" task with PADI-web (e‧g. countries, dates, symptoms, etc.) for each disease (e‧g. ASF, FMD, BTV, AI). Article_user_label indicates the manually evaluations of articles. Note that it was easy to evaluate the articles/signals that were relevant (outbreak-related) or irrelevant (not relevant to the article nor to the extracted info) or even potentially relevant articles (economy, vaccination, etc). For some diseases (like influenza) there are other categories: - Potentially/Irrelevant where the article was relevant or potentially relevant, but the extraction was irrelevant - Irrelevant/Potentially where the article was irrelevant, but the information extraction was relevant Les données sont téléchargées sur PADI-web pour la période du 1er janvier au 28 juin 2016 pour les quatre maladies étudiées, à savoir la peste porcine africaine (PPA), la fièvre aphteuse (Fièvre aphteuse), la fièvre catarrhale du mouton (Fièvre aphteuse) et la grippe aviaire (GA). Cet ensemble de données indique les informations associées à la tâche "extraction d'informations" avec PADI-web (par ex. pays, dates, symptômes, etc.) pour chaque maladie (par ex. peste porcine africaine, fièvre aphteuse, fièvre aphteuse, TVB, grippe aviaire). Article_user_label indique les évaluations manuelles des articles. Notez qu'il était facile d'évaluer les articles/signaux qui étaient pertinents (liés au foyer) ou non pertinents (sans rapport avec l'article ni avec l'information extraite) ou même les articles potentiellement pertinents (économie, vaccination, etc.). Pour certaines maladies (comme la grippe), il existe d'autres catégories : - Potentiellement ou potentiellement pertinent lorsque l'article était pertinent ou potentiellement pertinent, mais l'extraction n'était pas pertinente - Non pertinent ou potentiellement pertinent lorsque l'article n'était pas pertinent, mais l'extraction d'information était pertinente.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The Plant RNA-Image Repository is a compiled database of plant images and omics data. The dataset contains images of four distinct plant maladies, including powdery mildew, rust, leaf spot, and blight, as well as gene expression and metabolite data. Using a high-resolution camera in a controlled environment at the facility of the various Agriculture Universities of the Khyber Pakhtunkhwa, Pakistan. We captured 26940 images of plants, where each class has different number of samples for each disease type. Each image was labelled with the disease type corresponding to it. The images were preprocessed by resizing them to 224x224 pixels and standardizing the pixel values. In addition to collecting images of the same plants, we also collected gene expression and metabolite data. We extracted RNA from the plant leaves using a commercial reagent and sequenced it on an Illumina HiSeq 4000 platform. The average length of the 100 million pairedend readings obtained was 150 base pairs. The unprocessed reads were trimmed with Trimmomatic and aligned with STAR against the reference genome. We counted the number of reads that mapped to each gene using featureCounts, and then identified differentially expressed genes between healthy and diseased plants using the DESeq2 package in R. Using gas chromatography-mass spectrometry (GC-MS), we gathered additional metabolite information. Using a methanol-water extraction protocol, we extracted metabolites from the plant leaves and analyzed the extracts using GC-MS.
This dataset can be used to classify the following diseases: 1. Actinic keratosis 2. Atopic Dermatitis 3. Benign keratosis 4. Dermatofibroma 5. Melanocytic nevus 6. Melanoma 7. Squamous cell carcinoma 8. Tinea Ringworm Candidiasis 9. Vascular lesion
https://www.databridgemarketresearch.com/privacy-policyhttps://www.databridgemarketresearch.com/privacy-policy
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
By Product Type (B Cell Inhibitors, T Cell Inhibitors, Tumor Necrosis Factor, Inhibitors, Interleukin Inhibitors, Immunosuppressants, Beta Interferons, Insulin, Others), Application (Graves Disease, Rheumatoid Arthritis, Hashimotos Thyroidtis, Vitiligo, Type 1 Diabetes, Pernicious Anemia, Others), Distribution Channel (Hospitals & Clinics, Diagnostic Centers, Drug Stores, Pharmacies, Others), Disease (Crohn's Disease, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis, Systemic Lupus Erythematosus, Psoriasis, Ankylosing Spondylitis), Mechanism of Action (TNF Inhibitors, IL Blockers, COX Inhibitors, Phosphodiesterase Type 4 Inhibitors), Diagnostic (Autoantibody Tests, Antinuclear Antibody Tests, Urinalysis, Comprehensive Metabolic Panel, Erythrocyte Sedimentation Rate), Treatment (Drugs, Physical Therapy), Product (Diagnostic Equipment, Drugs, Therapeutic & Monitoring Equipment)' |
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa |
Market Players Covered |
Autoimmune Inc (U.S.), Siemens Healthcare Private Limited (Germany), LUPIN.(India), Thermo Fisher Scientific Inc (U.S.), Beckman Coulter, Inc (U.S.), Chugai Pharmaceutical Co., Ltd.(Japan), GlaxoSmithKline plc (UK), Biogen(U.S.), Bayer AG (Germany), Genentech, Inc (U.S.), Merck Sharp & Dohme Corp (U.S.), Bristol-Myers Squibb Company (U.S.), AstraZeneca (UK), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc.(U.S.), Eli Lilly and Company(U.S.), Johnson & Johnson Services, Inc.(U.S.), Amgen Inc (U.S.), and Abbott (U.S.) |
Market Opportunities |
|
https://www.databridgemarketresearch.com/privacy-policyhttps://www.databridgemarketresearch.com/privacy-policy
Report Metric |
Details |
Forecast Period |
2023-2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Diagnosis (MRI, CT Scan, Genetic Testing, Others), Treatment Type (Symptomatic Therapy, Disease-Modifying Therapy, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Teva Pharmaceutical Industries Ltd (Israel), Amneal Pharmaceuticals LLC. (U.S.), Elekta AB (Sweden), Alnylam Pharmaceuticals, Inc (U.S.), Apotex Inc (Canada), Armata Pharmaceuticals, Inc. (U.S.), Pfizer Inc (U.S.), H. Lundbeck A/S (Denmark), Alterity Therapeutics (Australia), Vertex Pharmaceuticals Incorporated (U.S.), SK Plc. (U.K.), Ceregene, Inc (U.S.), SOM BIOTECH (Spain), Palobiofarma (Spain), and Ipsen Pharma (France) |
Market Opportunities |
|
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
This is the historic impact factors of Journal Des Maladies Vasculaires computed for each year in CSV format. The first column shows the exaly JournalID for mixing this table with those of other journals
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
This is the historic impact factors of Medecine Des Maladies Metaboliques computed for each year in CSV format. The first column shows the exaly JournalID for mixing this table with those of other journals
https://www.databridgemarketresearch.com/privacy-policyhttps://www.databridgemarketresearch.com/privacy-policy
Content | Global Infectious Disease Diagnostics Market, By Product (Reagents, Assays, Instrument), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Techniques (Conventional Techniques, Biochemical Techniques, Molecular Techniques), Condition (Bacterial Infection, Viral Infection, CNS Infections, Cardiovascular Infection, Fungal Infection, GI Infections, Sexually Transmitted Disease and Others), End User (Diagnostic Laboratories, Academic and Medical Institutes, Contract Research Organization, Hospitals and Surgical Centers, Ambulatory Clinics and Home Healthcare), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029. |
Observation maladies cryptogamiques sur des Témoins Non Traités du réseau BSV
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
This is the historic impact factors of EMC - PĂ©diatrie - Maladies Infectieuses computed for each year in CSV format. The first column shows the exaly JournalID for mixing this table with those of other journals
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Le présent fichier d'occurrence donne la distribution des vecteurs de maladie au Bénin. A partir des maladies, les vecteurs ont été identifiés à l'aide des spécialistes et des gestionnaires des bases de données.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This heart disease dataset is curated by combining 3 popular heart disease datasets. The first dataset (Collected from Kaggle) contains 70000 records with 11 independent features which makes it the largest heart disease dataset available so far for research purposes. These data were collected at the moment of medical examination and information given by the patient. Second and third datasets contain 303 and 293 intstances respectively with 13 common features. The three datasets used for its curation are:Cardio Data (Kaggle Dataset)Cleveland (UCI Machine Learning Repository)Hungarian (UCI Machine Learning Repository)